FDA medical device regulation

Bill Ackman's two co-leads supply 17% of Precision Neuroscience's $250 million round

Precision Neuroscience raised $250 million at just over a $1 billion valuation, $42.5 million of it from Bill Ackman's Pershing Square and his institute. The other $207.5 million came in undisclosed amounts, so the round names its generalist investors without showing what they paid.